Intas Pharmaceuticals Ltd and Henlius Biotech enter into Exclusive License Agreement to commercialise serplulimab - A Novel Anti-PD1 mAb in Europe & India
Oct 28, 2023
Ahmedabad (Gujarat) [India], October 28: Intas Pharmaceuticals Limited ("Intas") has entered into an exclusive license agreement with Shanghai Henlius Biotech, Inc. (2696.HK) for the...